Athira Pharma Inc. Made Headway
Fri, Nov 01, 2024 at 07:35 PM
Athira Pharma Inc. (ATHA:NASDAQ) rocketted at $0.61, a gain of 41.5%. On Fri, Nov 01, 2024, ATHA:NASDAQ touched a New 2-Week High of $0.61. The stock appeared on our News Catalysts scanner on Tue, Oct 29, 2024 at 09:37 PM in the 'INVESTOR UPDATE' category. From Fri, Oct 18, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
About Athira Pharma Inc. (ATHA:NASDAQ)
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration.
Top 10 Gainers:
- Vast Renewables Limited (VSTE:NASDAQ), 140%
- ChromaDex Corporation (CDXC:NASDAQ), 67.91%
- Athira Pharma Inc. (ATHA:NASDAQ), 41.53%
- Proto Labs, Inc. (PRLB:NYSE), 38.69%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 36.3%
- Interface, Inc. (TILE:NASDAQ), 33.03%
- Globalstar, Inc. (GSAT:NYSEMKT), 31.43%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 27.71%
- Nexalin Technology Inc. (NXL:NASDAQ), 26.91%
- GRI Bio Inc Com (GRI:NASDAQ), 25.28%